Publisher Correction: The Jumonji-C oxygenase JMJD7 catalyzes (3<i>S</i>)-lysyl hydroxylation of TRAFAC GTPases

June 27th, 2018 by Suzana Markolovic

Publisher Correction: The Jumonji-C oxygenase JMJD7 catalyzes (3S)-lysyl hydroxylation of TRAFAC GTPases

Publisher Correction: The Jumonji-C oxygenase JMJD7 catalyzes (3<i>S</i>)-lysyl hydroxylation of TRAFAC GTPases, Published online: 27 June 2018; doi:10.1038/s41589-018-0104-6

Publisher Correction: The Jumonji-C oxygenase JMJD7 catalyzes (3S)-lysyl hydroxylation of TRAFAC GTPases
  • Posted in Nat Chem Biol, Publications
  • Comments Off on Publisher Correction: The Jumonji-C oxygenase JMJD7 catalyzes (3<i>S</i>)-lysyl hydroxylation of TRAFAC GTPases

[ASAP] Optical Recording of Zn<sup>2+</sup> Dynamics in the Mitochondrial Matrix and Intermembrane Space with the GZnP2 Sensor

June 25th, 2018 by Dylan H. Fudge, Raymond Black, Lea Son, Kate LeJeune, Yan Qin

TOC Graphic

ACS Chemical Biology
DOI: 10.1021/acschembio.8b00319
  • Posted in ACS Chemical Biology, Publications
  • Comments Off on [ASAP] Optical Recording of Zn<sup>2+</sup> Dynamics in the Mitochondrial Matrix and Intermembrane Space with the GZnP2 Sensor

Designing microbial consortia with defined social interactions

June 25th, 2018 by Wentao Kong

Designing microbial consortia with defined social interactions

Designing microbial consortia with defined social interactions, Published online: 25 June 2018; doi:10.1038/s41589-018-0091-7

Synthetic microbial consortia were engineered as experimental models of bacterial interactions within ecosystems, and mathematical models of their behavior were used to design more complex microbial systems with additional interactions.

Sarpagan bridge enzyme has substrate-controlled cyclization and aromatization modes

June 25th, 2018 by Thu-Thuy T. Dang

Sarpagan bridge enzyme has substrate-controlled cyclization and aromatization modes

Sarpagan bridge enzyme has substrate-controlled cyclization and aromatization modes, Published online: 25 June 2018; doi:10.1038/s41589-018-0078-4

Three homologous cytochrome P450s from monoterpene indole alkaloid-producing plants enable the identification of sarpagan bridge enzyme, which catalyzes either cyclization or aromatization to yield sarpagan or β-carboline alkaloids, respectively.
  • Posted in Nat Chem Biol, Publications
  • Comments Off on Sarpagan bridge enzyme has substrate-controlled cyclization and aromatization modes

Metabolic engineering of a carbapenem antibiotic synthesis pathway in <i>Escherichia coli</i>

June 25th, 2018 by Helena Shomar

Metabolic engineering of a carbapenem antibiotic synthesis pathway in Escherichia coli

Metabolic engineering of a carbapenem antibiotic synthesis pathway in <i>Escherichia coli</i>, Published online: 25 June 2018; doi:10.1038/s41589-018-0084-6

Efficient production of a simple carbapenem antibiotic in Escherichia coli is achieved by a combination of feedback-resistant enzymes for increased precursor biosynthesis and inhibition of fatty acid synthesis for tolerance toward the toxic product.
  • Posted in Nat Chem Biol, Publications
  • Comments Off on Metabolic engineering of a carbapenem antibiotic synthesis pathway in <i>Escherichia coli</i>

Cleavage of a carbon–fluorine bond by an engineered cysteine dioxygenase

June 25th, 2018 by Jiasong Li

Cleavage of a carbon–fluorine bond by an engineered cysteine dioxygenase

Cleavage of a carbon–fluorine bond by an engineered cysteine dioxygenase, Published online: 25 June 2018; doi:10.1038/s41589-018-0085-5

Engineered variants of cysteine dioxygenase containing a halogen-substituted tyrosine analog provide insights into the process of Cys–Tyr cross-link formation and indicate that the enzyme can catalyze oxidative cleavage of a carbon–fluorine bond.
  • Posted in Nat Chem Biol, Publications
  • Comments Off on Cleavage of a carbon–fluorine bond by an engineered cysteine dioxygenase

Kinome rewiring reveals AURKA limits PI3K-pathway inhibitor efficacy in breast cancer

June 25th, 2018 by Hayley J. Donnella

Kinome rewiring reveals AURKA limits PI3K-pathway inhibitor efficacy in breast cancer

Kinome rewiring reveals AURKA limits PI3K-pathway inhibitor efficacy in breast cancer, Published online: 25 June 2018; doi:10.1038/s41589-018-0081-9

Proteomic mapping of dynamic changes in kinase signaling after drug treatment identifies that AURKA inhibition is required for drug sensitivity, representing a new co-targeting opportunity with PI3K, AKT, or mTOR inhibitors in breast cancer.
  • Posted in Nat Chem Biol, Publications
  • Comments Off on Kinome rewiring reveals AURKA limits PI3K-pathway inhibitor efficacy in breast cancer

Unraveling the rewired network

June 25th, 2018 by Vinayak Palve

Unraveling the rewired network

Unraveling the rewired network, Published online: 25 June 2018; doi:10.1038/s41589-018-0083-7

Adaptive survival signaling can promote resistance to individual kinase inhibitors. A new study used a pathway-based approach to characterize shared kinome-wide rewiring mechanisms across multiple kinase inhibitors and developed rational drug-combination approaches that target cross-talk between two signaling pathways.

[ASAP] A Bifunctional Noncanonical Amino Acid: Synthesis, Expression, and Residue-Specific Proteome-wide Incorporation

June 21st, 2018 by Jan-Erik Hoffmann, Dmytro Dziuba, Frank Stein, Carsten Schultz

TOC Graphic

Biochemistry
DOI: 10.1021/acs.biochem.8b00397

[ASAP] So Close, yet Sulfur Away: Opening the Nitrogenase Cofactor Structure Creates a Binding Site

June 20th, 2018 by Kazimer L. Skubi, Patrick L. Holland

TOC Graphic

Biochemistry
DOI: 10.1021/acs.biochem.8b00529